7324 J. Agric. Food Chem., Vol. 51, No. 25, 2003
Caris-Veyrat et al.
observed (Z)-isomerization of â-carotene in such an oxidative
system (26). It is known that a (Z)-olefin is at least 10 times
more reactive than the (E)-isomer in a competitive oxidation
by a metalloporphyrin catalytic system similar to the one we
used (27). However, the mechanism by which isomerization
occurs is not known. It could be either metal- (28) or acid-
catalyzed (29).
Further studies are underway to detect oxidative cleavage
compounds of lycopene formed by the action of extracts of cells
containing cytochrome P450 enzymes and in vivo.
LITERATURE CITED
(1) Olson, J. A. Carotenoids and human health. Arch. Latin. Nutr.
1999, 49, 7S-11S.
(2) Krinsky, N. I. Carotenoids as antioxidants. Nutrition 2001, 17,
Compounds having a molecular weight of 553 ) Mlycopene
+
16 + 1 were detected in a positive electrospray mode, suggesting
the presence of epoxide groups on the chain of lycopene, but
no other information on the structure could be obtained, because
UV-vis spectra were not possible to obtain for these peaks. In
a previous study with a similar such catalytic system, we had
been able to detect â-carotene epoxides (26).
815-817.
(3) Hughes, D. A. Effects of carotenoids on human immune function.
Proc. Nutr. Soc. 1999, 58, 713-718.
(4) Stahl, W.; Ale-Agha, N.; Polidori, M. C. Nonantioxidant
properties of carotenoids. Biol. Chem. 2002, 383, 553-558.
(5) King, T. J.; Khachik, F.; Bortkewicz, H.; Fukushima, S.;
Morioka, S.; Bertram, J. S. Metabolites of dietary carotenoids
as potential cancer preventive agents. Pure Appl. Chem. 1997,
69, 2135-2140.
(6) Khachik, F.; Bertram, J.; Huang, M.-T.; Fahey, J. W.; Talalay,
P. Dietary carotenoids and their metabolites as potentially useful
chemoprotective agents against cancer. In Antioxidant Food
Supplements in Human Health; Academic Press: London, 1999;
pp 203-229.
(7) Bertram, J. S.; King, T.; Fukishima, L.; Khachik, F.; Sen, C.
K.; Sies, H.; Baeuerle, P. A. Enhanced activity of an
oxidation product of lycopene found in tomato products and
human serum relevant to cancer prevention. In Antioxidant Redox
Regulatory Genes; Academic Press: London, 2000; pp 409-
424.
(8) Agarwal, S.; Rao, A. V. Tomato lycopene and its role in human
health and chronic diseases. Can. Med. Assoc. J. 2000, 163, 739-
744.
(9) Khachik, F.; Carvalho, L.; Bernstein, P. S.; Muir, G. J.; Zhao,
D. Y.; Katz, N. B. Chemistry, distribution, and metabolism of
tomato carotenoids and their impact on human health. Exp. Biol.
Med. 2002, 227, 845-851.
(10) Rao, A. V.; Agarwal, S. Role of lycopene as antioxidant
carotenoid in the prevention of chronic diseases: A review. Nut.
Res. 1999, 19, 305-323.
(11) Rao, A. V. R.; Agarwal, S. Role of antioxidant lycopene in cancer
and heart disease. J. Am. Coll. Nutr. 2000, 19, 563-569.
(12) Hadley, C. W.; Miller, E. C.; Schwartz, S. J.; Clinton, S. K.
Tomatoes, lycopene, and prostate cancer: Progress and promise.
Exp. Biol. Med. 2002, 227, 869-880.
(13) Di Mascio, P.; Kaiser, S.; Sies, H. Lycopene as the most efficient
biological carotenoid singlet oxygen quencher. Arch. Biochem.
Biophys. 1989, 274, 532-538.
(14) Khachik, F.; Spangler, C. J.; Smith, J. C.; Canfield, L.;
Steck, A.; Pfander, H. Identification, quantification, and relative
concentrations of carotenoids and their serum metabolites in
human milk and serum. Anal. Chem. 1997, 69, 1873-1881.
(15) Kim, S. J.; Nara, E.; Kobayashi, H.; Terao, J.; Nagao, A.
Formation of cleavage products by autoxidation of lycopene.
Lipids 2001, 36, 191-199, and references therein.
(16) Jorgensen, K.; Skibsted, L. H. Carotenoid scavenging of radicals,
effect of carotenoid structure, and oxygen partial pressure on
antioxidative activity. Z. Lebensm. Unters. Forsch. 1993, 196,
423-429.
(17) Karrer, P.; Jucker, E. Carotenoids; Elsevier: Paris, 1950.
(18) Ben-Aziz, A.; Britton, G.; Goodwin, T. W. Carotene epoxides
of Lycopersicon esculentum. Phytochemistry 1973, 12, 2759-
2764.
(19) Ukai, N.; Etoh, H.; Yagi, H.; Ina, K.; Oshima, S.; Ojima, F.;
Sakamoto, H.; Ishiguro, Y. Photosensitized oxygenation of
lycopene. Biosci. Biotech. Biochem. 1994, 58, 1718-1719.
(20) Maerki-Fischer, E.; Uebelhart, P.; Eugster, C. H. 10′-Apolyco-
pin-10′-ol und 10′-apolycopin-10′-saure aus Blueten der
Rosenhybride ‘Marechal Niel’ HelV. Chim. Acta 1987, 70, 1994-
2002.
The evolution in time of these compounds was followed in
a relative quantitative manner by using the total ion chromato-
grams (TIC) obtained by mass detection. As for UV-vis
detection, we assumed that the area of the peaks of a mass
chromatogram obtained at a precise mass (see for example
Figure 6) is proportional to the quantity of the compound. Thus,
by following the evolution in time of the peak areas at a precise
molecular weight, we obtained information on the evolution of
the relative quantity of the compound considered. When several
peaks with close retention time were obtained at the same
molecular weight, indicating the presence of (Z)-isomers, we
added the areas of all peaks. Thus, for the lycopene monoxides,
their global evolution in time is shown in Figure 7A. Their
amount was at the maximum after 1 h of reaction and then
decreased regularly until 96 h. For the longest-chain apo-
lycopenal (i.e., apo-6′-lycopenal (1)), its amount increased until
5 h and then decreased continuously until complete disappear-
ance at 96 h (Figure 7A). For the apo-13-lycopenone (7a), apo-
11-lycopenal (8) and apo-9-lycopenone (9), their amount
increased quickly during the first 5 h (Figure 7B) and then
more slowly but continuously until 96 h. For apo-15-lycopenal
(6a) and apo-14′-lycopenal (5), their evolution is comparable
to the short-chain apo-lycopenals until 48 h, but then their
amount decreased until 96 h (Figure 7C). For the longer-chain
apo-12′-lycopenal (4), apo-10′-lycopenal (3), and apo-8′-lyco-
penal (2), their amount increased until 5 h, but then their
evolution was not regular between 5 and 48 h (Figure 7D).
It was stable and increased for the apo-12′-lycopenal (4),
decreased and increased for the apo-10′-lycopenal (3) and
apo-8′-lycopenal (2), but after 48 h, for all of them, their
amount drastically decreased until 96 h to almost complete
disappearance in the case of (2) and (3). To summarize the
evolution of apo-lycopenals, we observed that the amount of
the shortest ones (apo-9-lycopenone (9), apo-13-lycopenone
(7a), and apo-11-lycopenal (8)) increased continuously until
96 h (Figure 7B), whereas the concentration of the longer ones
(apo-6′-lycopenal (1), apo-8′-lycopenal (2), apo-10′-lyco-
penal (3), apo-12′- lycopenal (4), apo-14′- lycopenal (5), and
apo-15-lycopenal (6a)) decreased after some time (5 or 48 h)
(Figure 7, parts A, C, and D). The evolution of different
products resulting from lycopene suggests a possible mechanism
of formation of these compounds (Figure 8). (Z)-Isomers are
first formed and then oxidized into epoxides forming the
lycopene monoxides. The epoxide groups undergo an oxidative
cleavage, giving rise to apo-lycopenals. Apo-lycopenals of all
sizes are formed simultaneously from the beginning of the
reaction, then the longer-chain apo-lycopenals (apo-15- to apo-
6′-lycopenal, 6a to 1) are oxidatively cleaved and thus trans-
formed into shorter apo-lycopenals/ones (apo-9- to apo-13-
lycopenal/ones, 9 to 7a).